FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Otto Benkert

Research Profile

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Schizophrenic Psychology

Geographic Areas

Germany

Physiology

Co-author Network

Publications

TOP 3
Otto Benkert; Armin Szegedi; Michael Philipp; Ralf Kohnen; Claus Heinrich; Anja Heukels; Monique van der Vegte-Senden; Ross A Baker; John H Simmons; Albert-Jan Schutte
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Klaus Mann; Justus Pankok; Bernhard Connemann; Michael Sohn; Joachim W Thüroff; Otto Benkert
Sleep investigations in erectile dysfunction.
Matthias J Müller; Wolfgang Rossbach; Klaus Mann; Joachim Röschke; Florian Müller-Siecheneder; M Blümler; Hermann Wetzel; H Russ; Ralf W Dittmann; Otto Benkert
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Otto Benkert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Otto Benkert; Armin Szegedi; Michael Philipp; Ralf Kohnen; Claus Heinrich; Anja Heukels; Monique van der Vegte-Senden; Ross A Baker; John H Simmons; Albert-Jan Schutte
Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
Journal of clinical psychopharmacology 2006;26(1):75-8.
2005: Klaus Mann; Justus Pankok; Bernhard Connemann; Michael Sohn; Joachim W Thüroff; Otto Benkert
Sleep investigations in erectile dysfunction.
Journal of psychiatric research 2005;39(1):93-9.
2004: Matthias J Müller; Wolfgang Rossbach; Klaus Mann; Joachim Röschke; Florian Müller-Siecheneder; M Blümler; Hermann Wetzel; H Russ; Ralf W Dittmann; Otto Benkert
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.
Pharmacopsychiatry 2004;37(4):157-62.
2003: Armin Szegedi; Matthias J Müller; Ion Anghelescu; Christoph Klawe; Ralf Kohnen; Otto Benkert
Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
The Journal of clinical psychiatry 2003;64(4):413-20.
2003: Karl Mann; Matthias J Müller; C Hiemke; Otto Benkert
[Standardized documentation procedure as a basis for improvement of process quality of treatment in psychiatric hospitals].
Der Nervenarzt 2003;74(3):235-44.
2002: Matthias J Müller; Hermann Wetzel; Franz-Xaver Eich; Werner Rein; Alain Puech; Otto Benkert
Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
Journal of clinical psychopharmacology 2002;22(6):554-60.
2002: Eugen Davids; Matthias J Müller; Nicole Rollmann; Martin Burkart; Eva Regier-Klein; Armin Szegedi; Otto Benkert; Wolgang Maier
Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(6):1079-87.
2002: Matthias J Müller; Hermann Wetzel; Otto Benkert
Differential effects of high-dose amisulpride versus flupentixol on latent dimensions of depressive and negative symptomatology in acute schizophrenia: an evaluation using confirmatory factor analysis.
International clinical psychopharmacology 2002;17(5):249-61.
2002: Otto Benkert; M Muller; Armin Szegedi
An overview of the clinical efficacy of mirtazapine.
Human psychopharmacology 2002;17 Suppl 1():S23-6.
2002: Gerhard Gründer; Otto Benkert
Prolactin secretion is not a core dimension of "atypicality".
Psychopharmacology 2002;162(1):93.
2002: Ralf Schlösser; Gerhard Gründer; Ion Anghelescu; A Hillert; S Ewald-Gründer; Christoph Hiemke; Otto Benkert
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.
Neuropsychobiology 2002;46(1):33-40.
2002: Matthias J Müller; Ralf Schlösser; Gisela Kapp-Steen; Benno Schanz; Otto Benkert
Patients' satisfaction with psychiatric treatment: comparison between an open and a closed ward.
The Psychiatric quarterly 2002;73(2):93-107.
2001: Gerhard Gründer; Ingo Vernaleken; Otto Benkert
[Which properties make a neuroleptic "atypical"?].
Der Nervenarzt 2001;72(11):833-43.
2001: Matthias J Müller; Otto Benkert
Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil.
Journal of affective disorders 2001;66(2-3):255-61.
2001: Klaus Mann; Justus Pankok; Joachim Leissner; Otto Benkert
Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction.
Psychopharmacology 2001;156(1):86-91.
2001: Matthias J Müller; J Ruof; M Graf-Morgenstern; H Porst; Otto Benkert
Quality of partnership in patients with erectile dysfunction after sildenafil treatment.
Pharmacopsychiatry 2001;34(3):91-5.
2001: M J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression.
Schizophrenia bulletin 2001;27(1):19-28.
2000: Peter Bartenstein; F Grünwald; T Kuwert; K Tatsch; O Sabri; Otto Benkert; Rudolf Fahlbusch; Gerhard Gründer; K Herholz; C Weiller
[Clinical applications of single photon emission tomography in neurology. 2. Dementia, psychoses, inflammation, skull and brain injuries].
Nuklearmedizin. Nuclear medicine 2000;39(8):218-32.
2000: Ion Anghelescu; Christoph Klawe; Otto Benkert
Orlistat in the treatment of psychopharmacologically induced weight gain.
Journal of clinical psychopharmacology 2000;20(6):716-7.
2000: P Bartenstein; F Grünwald; T Kuwert; K Tatsch; O Sabri; Otto Benkert; Rudolf Fahlbusch; Gerhard Gründer; K Herzholz; C Weiller
[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease].
Nuklearmedizin. Nuclear medicine 2000;39(7):180-95.
2000: Matthias J Müller; Armin Szegedi; Hermann Wetzel; Otto Benkert
Moderate and severe depression. Gradations for the Montgomery-Asberg Depression Rating Scale.
Journal of affective disorders 2000;60(2):137-40.
2000: Otto Benkert; Armin Szegedi; Ralf Kohnen
Mirtazapine compared with paroxetine in major depression.
The Journal of clinical psychiatry 2000;61(9):656-63.
2000: B Loerch; Armin Szegedi; Ralf Kohnen; Otto Benkert
The primary care evaluation of mental disorders (PRIME-MD), German version: a comparison with the CIDI.
Journal of psychiatric research 2000;34(3):211-20.
2000: Ralf Schlösser; Hermann Wetzel; H Dörr; Wolfgang Rossbach; Christoph Hiemke; Otto Benkert
Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers.
Psychoneuroendocrinology 2000;25(4):377-88.
2000: Matthias J Müller; Wolfgang Rossbach; Eugen Davids; Hermann Wetzel; Otto Benkert
[Evaluation of standardized training for the "Positive and Negative Syndrome Scale" (PANSS)].
Der Nervenarzt 2000;71(3):195-204.
1999: Matthias J Müller; Gerhard Gründer; Hermann Wetzel; Florian Müller-Siecheneder; P Marx-Dannigkeit; Otto Benkert
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial.
Psychiatry research 1999;89(3):275-80.
1999: M J Müller; Hermann Wetzel; Armin Szegedi; Otto Benkert
Three dimensions of depression in patients with acute psychotic disorders: a replication study.
Comprehensive psychiatry 1999;40(6):449-57.
1999: Matthias J Müller; P Marx-Dannigkeit; Ralf Schlösser; Hermann Wetzel; D Addington; Otto Benkert
The Calgary Depression Rating Scale for Schizophrenia: development and interrater reliability of a German version (CDSS-G).
Journal of psychiatric research 1999;33(5):433-43.
1999: Gerhard Gründer; Matthias J Müller; J Andreas; N Heydari; Hermann Wetzel; Ralf Schlösser; S Schlegel; Otmar Nickel; D Eissner; Otto Benkert
Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
Psychopharmacology 1999;146(1):81-6.
1999: B Loerch; M Graf-Morgenstern; Martin Hautzinger; S Schlegel; C Hain; J Sandmann; Otto Benkert
Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
The British journal of psychiatry : the journal of mental science 1999;174():205-12.
1999: Gerhard Gründer; Hermann Wetzel; Ralf Schlösser; Ion Anghelescu; A Hillert; K Lange; Christoph Hiemke; Otto Benkert
Neuroendocrine response to antipsychotics: effects of drug type and gender.
Biological psychiatry 1999;45(1):89-97.
1998: Ralf Schlösser; Joachim Röschke; Wolfgang Rossbach; Otto Benkert
Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(4):273-8.
1998: Martin Burkart; Reinhard Heun; W Maier; Otto Benkert
[Dementia screening in routine clinical practice. A comparative analysis of MMSE, SIDAM and ADAS].
Der Nervenarzt 1998;69(11):983-90.
1998: J Sandmann; Bernd Lörch; B Bandelow; Sebastian Härtter; P Winter; Christoph Hiemke; Otto Benkert
Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine.
Pharmacopsychiatry 1998;31(4):117-21.
1998: Reinhard Heun; Martin Burkart; C Wolf; Otto Benkert
Effect of presentation rate on word list learning in patients with dementia of the Alzheimer type.
Dementia and geriatric cognitive disorders 1998;9(4):214-8.
1998: Hermann Wetzel; Gerhard Gründer; A Hillert; M Philipp; Wagner Farid Gattaz; H Sauer; G Adler; J Schröder; Werner Rein; Otto Benkert
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Psychopharmacology 1998;137(3):223-32.
1998: Eugen Davids; Gerhard Gründer; Hermann Wetzel; Otto Benkert
[Psychopharmacotherapy in pregnancy and breast feeding].
Fortschritte der Neurologie-Psychiatrie 1998;66(5):207-24.
1998: Martin Burkart; Reinhard Heun; Otto Benkert
Serial position effects in dementia of the Alzheimer type.
Dementia and geriatric cognitive disorders 1998;9(3):130-6.
1998: Florian Müller-Siecheneder; Matthias J Müller; A Hillert; Armin Szegedi; Hermann Wetzel; Otto Benkert
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.
Journal of clinical psychopharmacology 1998;18(2):111-20.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; M Philipp; Otto Benkert
Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.
Journal of affective disorders 1997;45(3):167-78.
1997: Joachim Röschke; Pia Kögel; Ralf Schlösser; Peter Wagner; Klaus Mann; Wolfgang Rossbach; Otto Benkert
Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects.
Psychopharmacology 1997;132(1):44-9.
1997: Armin Szegedi; Hermann Wetzel; D Angersbach; G C Dunbar; H Schwarze; M Philipp; Otto Benkert
A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
Pharmacopsychiatry 1997;30(3):97-105.
1997: Reinhard Heun; Martin Burkart; Otto Benkert
Effect of repetition and inspection times on picture recall in patients with dementia of Alzheimer type.
Dementia and geriatric cognitive disorders 1997;8(3):152-6.
1997: Otto Benkert; Armin Szegedi; Hermann Wetzel; H J Staab; W Meister; M Philipp
Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
Acta psychiatrica Scandinavica 1997;95(4):288-96.
1997: Otto Benkert; M Graf-Morgenstern; A Hillert; J Sandmann; S C Ehmig; H Weissbecker; H M Kepplinger; K Sobota
Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.
The Journal of nervous and mental disease 1997;185(3):151-8.
1997: Reinhard Heun; Martin Burkart; Otto Benkert
Improvement of picture recall by repetition in patients with dementia of Alzheimer type.
International journal of geriatric psychiatry 1997;12(1):85-92.
1996: Otto Benkert; Gerhard Gründer; Hermann Wetzel; david Hackett
A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
Journal of psychiatric research 1996;30(6):441-51.
1996: Otto Benkert; Armin Szegedi; Hermann Wetzel
Minimum effective dose for antidepressants--an obligatory requirement for antidepressant drug evaluation?
International clinical psychopharmacology 1996;11(3):177-85.
1996: Klaus Mann; H Bauer; Christoph Hiemke; Joachim Röschke; Hermann Wetzel; Otto Benkert
Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(3):163-8.
1996: Gerhard Gründer; Hermann Wetzel; Ralf Schlösser; Otto Benkert
Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Pharmacopsychiatry 1996;29(2):72-8.
1996: A Hillert; J Sandmann; S C Ehmig; K Sobota; W Weisbecker; H M Kepplinger; Otto Benkert
Psychopharmacological drugs as represented in the press: results of systematic analysis of newspapers and popular magazines.
Pharmacopsychiatry 1996;29(2):67-71.
1996: K Mann; T Klingler; S Noe; Joachim Röschke; S Müller; Otto Benkert
Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.
Archives of sexual behavior 1996;25(1):1-16.
1995: Otto Benkert
[Clinical evaluation of mentally incompetent patients. Mainz recommendation for correction of the drug treatment law].
Der Nervenarzt 1995;66(11):864-8.
1995: A Hillert; J Sandmann; S C Ehmig; H Weisbecker; K Sobota; H M Kepplinger; Otto Benkert
[Psychopharmaceutical drugs in the mass media. Results of a systematic analysis of text contents and images].
Der Nervenarzt 1995;66(11):835-44.
1995: H Gerbaldo; M P Fickinger; Hermann Wetzel; A Helisch; M Philipp; Otto Benkert
Primary enduring negative symptoms in schizophrenia and major depression.
Journal of psychiatric research 1995;29(4):297-302.
1995: Hermann Wetzel; Armin Szegedi; C Hain; J Wiesner; S Schlegel; Otto Benkert
Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
Psychopharmacology 1995;119(2):231-8.
1995: Gerhard Gründer; Hermann Wetzel; A Hillert; E Jochum; Christoph Hiemke; Otto Benkert
The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.
Psychopharmacology 1995;117(4):472-8.
1995: Otto Benkert; Florian Müller-Siecheneder; Hermann Wetzel
Dopamine agonists in schizophrenia: a review.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5 Suppl():43-53.
1995: Klaus Mann; Joachim Röschke; Otto Benkert; J Aldenhoff; M Nink; Jürgen Beyer; Hendrik Lehnert
Effects of corticotropin-releasing hormone on respiratory parameters during sleep in normal men.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1995;103(4):233-40.
1994: Hermann Wetzel; A Hillert; Gerhard Gründer; Otto Benkert
Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
The American journal of psychiatry 1994;151(10):1499-502.
1994: Hermann Wetzel; J Wiesner; Christoph Hiemke; Otto Benkert
Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers.
Journal of psychiatric research 1994;28(5):461-73.
1994: W Maier; Otto Benkert
Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies.
Psychopharmacology 1994;115(4):495-501.
1994: U H Frommberger; B Tettenborn; R Buller; Otto Benkert
Panic disorder in patients with dizziness.
Archives of internal medicine 1994;154(5):590-1.
1994: H Gerbaldo; A Helisch; B Schneider; M Philipp; Otto Benkert
Subtypes of negative symptoms: the primary subtype in schizophrenic and non-schizophrenic patients.
Progress in neuro-psychopharmacology & biological psychiatry 1994;18(2):311-20.
1994: Joachim Röschke; Klaus Mann; J B Aldenhoff; Otto Benkert
Functional properties of the brain during sleep under subchronic zopiclone administration in man.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(1):21-30.
1994: S Schlegel; H Steinert; Andreas Bockisch; Klaus Hahn; Ralf Schlösser; Otto Benkert
Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.
European archives of psychiatry and clinical neuroscience 1994;244(1):49-51.
1994: W Maier; R Herr; Michael Gänsicke; Dirk Lichtermann; K Houshangpour; Otto Benkert
Recurrent brief depression in general practice. Clinical features, comorbidity with other disorders, and need for treatment.
European archives of psychiatry and clinical neuroscience 1994;244(4):196-204.
1994: W Maier; R Herr; Dirk Lichtermann; Michael Gänsicke; Otto Benkert; G Faust
Brief depression among patients in general practice. Prevalence and variation by recurrence and severity.
European archives of psychiatry and clinical neuroscience 1994;244(4):190-5.
1994: W Seiler; Hermann Wetzel; A Hillert; G Schöllnhammer; Otto Benkert; Christoph Hiemke
Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
Experimental and clinical endocrinology 1994;102(4):326-33.
1994: Axel Steiger; Otto Benkert; Florian Holsboer
Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men.
Neuropsychobiology 1994;30(2-3):101-5.
1993: Otto Benkert; Hermann Wetzel; Armin Szegedi
Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
International clinical psychopharmacology 1993;8 Suppl 1():3-14.
1993: Hermann Wetzel; Otto Benkert
Dopamine autoreceptor agonists in the treatment of schizophrenic disorders.
Progress in neuro-psychopharmacology & biological psychiatry 1993;17(4):525-40.
1993: Axel Steiger; A Gerken; Otto Benkert; Florian Holsboer
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(2):117-26.
1993: U Frommberger; S Hurth-Schmidt; H Dieringer; B Tettenborn; R Buller; Otto Benkert
[Panic disorder and vertigo. On the psychopathologic differentiation between neurologic and psychiatric disease].
Der Nervenarzt 1993;64(6):377-83.
1993: Axel Steiger; Florian Holsboer; Otto Benkert
Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls.
Acta psychiatrica Scandinavica 1993;87(5):358-63.
1993: M Philipp; R Kohnen; Otto Benkert
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.
International clinical psychopharmacology 1993;7(3-4):149-53.
1993: Gerhard Gründer; Hermann Wetzel; E Hammes; Otto Benkert
Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression.
Psychopharmacology 1993;111(1):123-6.
1992: W Maier; Dirk Lichtermann; J Minges; Reinhard Heun; Joachim Hallmayer; Otto Benkert
Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study.
The American journal of psychiatry 1992;149(12):1666-73.
1992: Otto Benkert; Gerhard Gründer; Hermann Wetzel
Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression.
Pharmacopsychiatry 1992;25(6):254-60.
1992: A Hillert; W Maier; Hermann Wetzel; Otto Benkert
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Pharmacopsychiatry 1992;25(5):213-7.
1992: M Banger; Otto Benkert; Joachim Röschke; T Herth; M Hebenstreit; M Philipp; J B Aldenhoff
Nimodipine in acute alcohol withdrawal state.
Journal of psychiatric research 1992;26(2):117-23.
1992: M Philipp; C D Delmo; R Buller; H Schwarze; P Winter; W Maier; Otto Benkert
Differentiation between major and minor depression.
Psychopharmacology 1992;106 Suppl():S75-8.
1991: Hermann Wetzel; U von Bardeleben; Florian Holsboer; Otto Benkert
[Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
Fortschritte der Neurologie-Psychiatrie 1991;59 Suppl 1():23-9.
1991: J Krause; T Herth; W Maier; Axel Steiger; S Schöneich; Otto Benkert
An interdisciplinary study towards a multiaxial classification of male sexual dysfunction.
Acta psychiatrica Scandinavica 1991;84(2):130-6.
1991: P Winter; M Philipp; R Buller; C D Delmo; H Schwarze; Otto Benkert
Identification of minor affective disorders and implications for psychopharmacotherapy.
Journal of affective disorders 1991;22(3):125-33.
1991: A Gerken; Hermann Wetzel; Otto Benkert
Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients.
Pharmacopsychiatry 1991;24(4):132-7.
1991: W Maier; R Rosenberg; N Argyle; R Buller; M Roth; S Brandon; Otto Benkert
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
European archives of psychiatry and clinical neuroscience 1991;241(1):22-30.
1991: R Buller; W Maier; I M Goldenberg; P W Lavori; Otto Benkert
Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
European archives of psychiatry and clinical neuroscience 1991;240(3):163-8.
1991: W Maier; S M Roth; N Argyle; R Buller; P Lavori; S Brandon; Otto Benkert
Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
European archives of psychiatry and clinical neuroscience 1991;241(3):151-8.
1991: Hermann Wetzel; Klaus Wiedemann; Florian Holsboer; Otto Benkert
Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients.
Psychopharmacology 1991;103(2):280-3.
1990: R Buller; Otto Benkert
[Panic attacks and panic disorder--diagnosis, validation and therapy].
Der Nervenarzt 1990;61(11):647-57.
1990: Otto Benkert; W Maier
The necessity of placebo application in psychotropic drug trials.
Pharmacopsychiatry 1990;23(5):203-5.
1990: K Wiedemann; Otto Benkert; Florian Holsboer
B-HT 920--a novel dopamine autoreceptor agonist in the treatment of patients with schizophrenia.
Pharmacopsychiatry 1990;23(1):50-5.
1989: W Maier; M Philipp; S Schlegel; I Heuser; Klaus Wiedemann; Otto Benkert
Diagnostic determinants of response to treatment with tricyclic antidepressants: a polydiagnostic approach.
Psychiatry research 1989;30(1):83-93.
1989: S Schlegel; W Maier; M Philipp; J B Aldenhoff; I Heuser; K Kretzschmar; Otto Benkert
Computed tomography in depression: association between ventricular size and psychopathology.
Psychiatry research 1989;29(2):221-30.
1989: Axel Steiger; Otto Benkert
Examination and treatment of sleep-related painful erections--a case report.
Archives of sexual behavior 1989;18(3):263-7.
1989: R Buller; U von Bardeleben; W Maier; Otto Benkert
Specificity of lactate response in panic disorder, panic with concurrent depression and major depression.
Journal of affective disorders 1989;16(2-3):109-13.
1989: Otto Benkert; W Maier
The interface of clinical psychopharmacology and psychopathology.
European archives of psychiatry and neurological sciences 1989;238(5-6):280-4.
1989: U von Bardeleben; Florian Holsboer; A Gerken; Otto Benkert
Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.
International clinical psychopharmacology 1989;4 Suppl 1():31-5.
1989: Axel Steiger; Otto Benkert; S Wöhrmann; D Steinseifer; Florian Holsboer
Effects of trimipramine on sleep EEG, penile tumescence and nocturnal hormonal secretion. A long-term study in 3 normal controls.
Neuropsychobiology 1989;21(2):71-5.
1989: W Maier; R Rosenberg; N Argyle; R Buller; M Roth; S Brandon; Otto Benkert
Avoidance behaviour and major depression in panic disorder: a report from the Cross-National Collaborative Panic Study.
Psychiatric developments 1989;7(2):123-42.
1988: Hermann Wetzel; I Heuser; Otto Benkert
Benzodiazepines for catatonic symptoms, stupor, and mutism.
Pharmacopsychiatry 1988;21(6):394-5.
1988: H Wetzel; Otto Benkert
[Receptors for neurotransmitters and psychiatric diseases].
Der Internist 1988;29(6):420-9.
1988: W Maier; I Heuser; M Philipp; S Schlegel; Otto Benkert
Diagnostic determinants of short-term spontaneous course of major depression.
Psychiatry research 1988;23(1):117-8.
1987: Axel Steiger; Florian Holsboer; A Gerken; Lothar Demisch; Otto Benkert
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression.
Pharmacopsychiatry 1987;20(6):262-9.
1987: W Maier; Otto Benkert
[Critical comments on the methods of assessing the effectiveness of antidepressive pharmacotherapy].
Der Nervenarzt 1987;58(10):595-602.